Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer
Jamil Nehme(University Medical Center Groningen), Marco Demaria(University Medical Center Groningen)
Cited by 12
Related Papers
Cellular Senescence: Defining a Path Forward
|Cell|2019|3k
Senescence and cancer — role and therapeutic opportunities
|Nature Reviews Clinical Oncology|2022|727
Algorithmic assessment of cellular senescence in experimental and clinical specimens
|Nature Protocols|2021|181
Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression
|Molecular Cell|2021|151
Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity
|The EMBO Journal|2022|106